483 Zhejiang Novus Pharmaceuticals Jan 2018

483 Zhejiang Novus Pharmaceuticals Jan 2018

Brian Ryan FDA, Sateesh Sathigari FDA, Liming Zhang FDA$119.00 - Available Now

FDA investigators audited the Zhejiang Novus Pharmaceuticals - Shaoxing, China facility and issued inspectional observations (via FDA 483) on 25 Jan 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 25 Jan 2018
  • Location: Shaoxing, China
  • FEI: 3013567704
Add To Cart